Psychological distress in relatives undergoing familial screening for hypertrophic or dilated cardiomyopathy: a prospective longitudinal observational cohort study

dc.contributor
Universitat de Girona. Facultat de Medicina
dc.contributor
Jordà Burgos, Paloma
dc.contributor
Marcos-Gragera, Rafael
dc.contributor.author
Puig Torrens, Júlia
dc.date.accessioned
2026-04-18T21:02:24Z
dc.date.available
2026-04-18T21:02:24Z
dc.date.issued
2025-11
dc.identifier
http://hdl.handle.net/10256/28678
dc.identifier.uri
https://hdl.handle.net/10256/28678
dc.description.abstract
BACKGROUND: Inherited cardiomyopathies, such as hypertrophic cardiomyopathy (HCM) and dilated (DCM) cardiomyopathy, can present with a wide range of symptoms and in some occasions lead to sudden cardiac death (SCD) in young individuals. Familial screening enables early identification of at-risk relatives, enabling prevention and improving clinical management. While the psychological burden of affected individuals has been well documented, the emotional impact of screening of at-risk asymptomatic relatives requires additional evaluation. Understanding the psychological responses to screening is essential for optimizing genetic counseling and psychological support for families. OBJECTIVE: To evaluate the psychological distress associated with familial cardiomyopathy screening, examining differences between gene-positive and gene-elusive families and changes over a one-year period. DESIGN: Prospective, longitudinal, observational cohort study conducted at the Familial Cardiomyopathies Unit, Hospital Universitari de Girona Dr. Josep Trueta over a 3-year period. The current study encompasses (1) a cross-sectional comparison of emotional distress at baseline between relatives belonging to gene-positive and gene-elusive families, and (2) a longitudinal evaluation of changes in distress after one-year of follow-up. PARTICIPANTS: Asymptomatic adult relatives of index patients diagnosed with HCM or DCM, recruited consecutively at their first visit for family screening. METHODS: A total of 168 participants will be recruited and divided into two subgroups based on family genetic status: gene-positive gene-elusive families. Psychological distress will be measured using the Hospital Anxiety and Depression Scale (HADS) at three time points: baseline (T0), immediately after disclosure of genetic results (Tg, for those belonging to gene-positive families only), and one-year follow-up (T1). Data will be recorded in an electronic Case Report Form and analyzed using descriptive and inferential statistics
dc.description.abstract
3
dc.format
application/pdf
dc.language
eng
dc.rights
Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Medicina (TFG)
dc.subject
Cardiopatia congènita
dc.subject
Congenital heart disease
dc.subject
Cor -- Malalties -- Aspectes genètics
dc.subject
Heart -- Diseases -- Genetic aspects
dc.subject
Cribratge genètic -- Aspectes psicològics
dc.subject
Genetic screening -- Psychological aspects
dc.subject
Pacients -- Satisfacció
dc.subject
Patient satisfaction
dc.subject
Cor -- Malalties -- Detecció precoç
dc.subject
Heart -- Diseases -- Early detection
dc.title
Psychological distress in relatives undergoing familial screening for hypertrophic or dilated cardiomyopathy: a prospective longitudinal observational cohort study
dc.type
info:eu-repo/semantics/bachelorThesis
dc.coverage
east=2.8199565410614014; north=41.99757439066319; name=Hospital Universitari de Girona Dr. Josep Trueta


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)